T1	chemical 18 22	drug
T2	chemical 23 34	fenofibrate
T3	disease_or_phenotypic_feature 80 98	myocardial disease
T4	disease_or_phenotypic_feature 115 127	hypertension
T5	disease_or_phenotypic_feature 132 146	hyperlipidemia
T6	chemical 163 170	biology
T7	disease_or_phenotypic_feature 186 202	C-cell carcinoma
T8	chemical 205 216	Amphetamine
T9	disease_or_phenotypic_feature 233 240	obesity
T10	chemical 242 250	Caffeine
T11	chemical 256 269	aminophylline
T12	disease_or_phenotypic_feature 278 286	seizures
T13	chemical 288 311	Aldosterone antagonists
T14	disease_or_phenotypic_feature 329 342	heart failure
T15	chemical 389 392	MVA
T16	chemical 398 407	biomarker
T17	disease_or_phenotypic_feature 411 417	glioma
T18	chemical 462 470	antigens
T19	chemical 485 495	biomarkers
T20	disease_or_phenotypic_feature 499 523	hepatocellular carcinoma
T21	chemical 548 558	Biomarkers
T22	disease_or_phenotypic_feature 578 591	heart failure
T23	chemical 617 621	acid
T24	disease_or_phenotypic_feature 644 657	cholesteatoma
T25	chemical 681 684	RAS
T26	chemical 711 715	drug
T27	disease_or_phenotypic_feature 789 804	pulmonary edema
T28	disease_or_phenotypic_feature 826 839	heart failure
T29	chemical 864 872	antigens
T30	disease_or_phenotypic_feature 882 890	melanoma
T31	chemical 897 904	aspirin
T32	chemical 906 926	acetylsalicylic acid
T33	chemical 936 946	inhibitors
T34	disease_or_phenotypic_feature 1010 1023	heart failure
T35	disease_or_phenotypic_feature 1038 1051	heart disease
T36	disease_or_phenotypic_feature 1098 1111	heart failure
T37	chemical 1113 1123	Dobutamine
T38	chemical 1128 1136	dopamine
T39	disease_or_phenotypic_feature 1171 1186	cardiac failure
T40	disease_or_phenotypic_feature 1191 1204	renal failure
T41	chemical 1220 1226	oxygen
T42	disease_or_phenotypic_feature 1308 1321	heart failure
T43	disease_or_phenotypic_feature 1323 1334	Lung tumors
T44	chemical 1426 1434	antigens
T45	chemical 1499 1510	cannabidiol
T46	chemical 1532 1536	drug
T47	disease_or_phenotypic_feature 1547 1555	seizures
T48	disease_or_phenotypic_feature 1563 1578	Dravet syndrome
T49	chemical 1590 1597	biology
T50	disease_or_phenotypic_feature 1601 1614	cholesteatoma
T51	chemical 1617 1628	Biochemical
T52	chemical 1633 1641	hormonal
T53	disease_or_phenotypic_feature 1653 1660	obesity
T54	disease_or_phenotypic_feature 1675 1682	cancers
T55	disease_or_phenotypic_feature 1779 1786	cancers
T56	chemical 1862 1865	dye
T57	disease_or_phenotypic_feature 1875 1904	hypogonadotropic hypogonadism
T58	disease_or_phenotypic_feature 1906 1924	hyperprolactinemia
T59	chemical 1929 1943	growth hormone
R1	treats Arg1:T2 Arg2:T3	
R2	treats Arg1:T2 Arg2:T4	
R3	treats Arg1:T2 Arg2:T5	
R4	causes_or_contributes_to Arg1:T10 Arg2:T12	
R5	causes_or_contributes_to Arg1:T11 Arg2:T12	
T60	missed_disease_or_phenotypic_feature 445 470	tumor-associated antigens
R6	causes_or_contributes_to Arg1:T18 Arg2:T60	
T61	corrected_chemical 932 946	ACE inhibitors
R7	treats Arg1:T31 Arg2:T34	
T62	corrected_disease_or_phenotypic_feature 1028 1051	ischaemic heart disease
R8	treats Arg1:T31 Arg2:T62	
R9	treats Arg1:T32 Arg2:T34	
R10	treats Arg1:T32 Arg2:T62	
R11	treats Arg1:T61 Arg2:T34	
R12	treats Arg1:T61 Arg2:T62	
R13	treats Arg1:T37 Arg2:T39	
R14	treats Arg1:T37 Arg2:T40	
R15	treats Arg1:T38 Arg2:T39	
R16	treats Arg1:T38 Arg2:T40	
T63	missed_disease_or_phenotypic_feature 1399 1434	tumor-associated oncofetal antigens
R17	causes_or_contributes_to Arg1:T44 Arg2:T63	
T64	corrected_disease_or_phenotypic_feature 1532 1555	drug-resistant seizures
R18	treats Arg1:T45 Arg2:T64	
R19	treats Arg1:T45 Arg2:T48	
T65	missed_disease_or_phenotypic_feature 1929 1954	growth hormone deficiency
T66	DONE 1956 1960	DONE
T67	missed_chemical 4 22	hypolipidemic drug
R20	treats Arg1:T67 Arg2:T3	
R21	treats Arg1:T67 Arg2:T4	
R22	treats Arg1:T67 Arg2:T5	
